Cargando…

Namodenoson in Advanced Hepatocellular Carcinoma and Child–Pugh B Cirrhosis: Randomized Placebo-Controlled Clinical Trial

SIMPLE SUMMARY: We conducted a phase II randomized placebo-controlled trial to investigate namodenoson, an A3 adenosine-receptor agonist, as 2nd-line treatment for advanced hepatocellular carcinoma and moderate hepatic dysfunction (Child–Pugh [CP] scores of 7–9). The study included 50 patients in th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stemmer, Salomon M., Manojlovic, Nebojsa S., Marinca, Mihai Vasile, Petrov, Petar, Cherciu, Nelly, Ganea, Doina, Ciuleanu, Tudor Eliade, Pusca, Ioana Adriana, Beg, Muhammad Shaalan, Purcell, William T., Croitoru, Adina-Emilia, Ilieva, Rumyana Nedyalkova, Natošević, Sladjana, Nita, Amedeia Lavinir, Kalev, Dimitar Nikolaev, Harpaz, Zivit, Farbstein, Motti, Silverman, Michael H., Bristol, David, Itzhak, Inbal, Fishman, Pnina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825785/ https://www.ncbi.nlm.nih.gov/pubmed/33430312 http://dx.doi.org/10.3390/cancers13020187

Ejemplares similares

Randomised clinical trial: A phase 2 double‐blind study of namodenoson in non‐alcoholic fatty liver disease and steatohepatitis
por: Safadi, Rifaat, et al.
Publicado: (2021)

The A3 adenosine receptor agonist, namodenoson, ameliorates non-alcoholic steatohepatitis in mice
por: Fishman, Pnina, et al.
Publicado: (2019)

Namodenoson Inhibits the Growth of Pancreatic Carcinoma via Deregulation of the Wnt/β-catenin, NF-κB, and RAS Signaling Pathways
por: Itzhak, Inbal, et al.
Publicado: (2023)

Introducing Edward N. Pugh, Jr.
por: Sparre Andersen, Olaf
Publicado: (2008)

Sofosbuvir/velpatasvir plus ribavirin for Child-Pugh B and Child-Pugh C hepatitis C virus-related cirrhosis
por: Liu, Chen-Hua, et al.
Publicado: (2021)

Potential Biomarkers for the Efficacy of PD-1-PD-L Blockade in Cancer
por: Grecea, Miruna, et al.
Publicado: (2021)

A multicenter, single-arm, basket design, phase II study of NC-6004 plus gemcitabine in patients with advanced unresectable lung, biliary tract, or bladder cancer
por: Volovat, Simona Ruxandra, et al.
Publicado: (2020)

Exploring Therapeutic Avenues in Lung Cancer: The Epigenetic Perspective
por: Munteanu, Raluca, et al.
Publicado: (2023)

Child Pugh and ALBI grade: past, present or future?
por: Rimini, Margherita, et al.
Publicado: (2020)

Laparoscopic Cholecystectomy in Child-Pugh Class C Cirrhotic Patients
por: Currò, Giuseppe, et al.
Publicado: (2005)

Electrocardiographic characteristics of cirrhotic patients and their association with Child‐Pugh score
por: Jahangiri, Soodeh, et al.
Publicado: (2023)

Alteration of prognostic efficacy of albumin‐bilirubin grade and Child‐Pugh score according to liver fibrosis in hepatocellular carcinoma patients with Child‐Pugh A following hepatectomy
por: Miyata, Tatsunori, et al.
Publicado: (2021)

Methotrexate enhances the anti-inflammatory effect of CF101 via up-regulation of the A(3 )adenosine receptor expression
por: Ochaion, Avivit, et al.
Publicado: (2006)

KRAS, NRAS and BRAF mutations in Greek and Romanian patients with colorectal cancer: a cohort study
por: Negru, Serban, et al.
Publicado: (2014)

Atezolizumab plus bevacizumab for patients with Child-Pugh-B in hepatocellular carcinoma
por: Itoh, Shinji, et al.
Publicado: (2022)

Hepatocellular carcinoma with child Pugh-A Cirrhosis treated with stereotactic body radiotherapy
por: Hasan, Shaakir, et al.
Publicado: (2017)

Influences of Oral Administration of Probiotics on Posthepatectomy Recovery in Patients in Child-Pugh Grade
por: Huang, Hao, et al.
Publicado: (2022)

Transarterial Chemoembolization for Patients with Unresectable Hepatocellular Carcinoma with Child-Pugh B7
por: Jiang, Jian-Qiang, et al.
Publicado: (2023)

Atezolizumab plus bevacizumab in patients with child–Pugh B advanced hepatocellular carcinoma
por: Cheon, Jaekyung, et al.
Publicado: (2023)

Cardiotoxicity Associated with Chemotherapy Used in Gastrointestinal Tumours
por: Radulescu, Liliana Maria, et al.
Publicado: (2021)

Is Laparoscopy-assisted Radical Gastrectomy Safe in Patients with Child-Pugh Class A Cirrhosis?
por: Kang, Sin Jae, et al.
Publicado: (2013)

Significance of an increase in the Child-Pugh score after radiotherapy in patients with unresectable hepatocellular carcinoma
por: Son, Seok Hyun, et al.
Publicado: (2014)

The Safety and Clinical Outcomes of Chemoembolization in Child-Pugh Class C Patients with Hepatocellular Carcinomas
por: Choi, Tae Won, et al.
Publicado: (2015)

Child-Pugh B or C Cirrhosis Increases the Risk for Bleeding Following Colonoscopic Polypectomy
por: Soh, Hosim, et al.
Publicado: (2020)

Multiphase CT-based prediction of Child-Pugh classification: a machine learning approach
por: Thüring, Johannes, et al.
Publicado: (2020)

Changes in Inflammatory Markers Predict the Prognosis of Resected Hepatocellular Carcinoma with Child–Pugh A
por: Zhou, Jing, et al.
Publicado: (2022)

Association of Thyroid Function and Severity of Illness in Liver Cirrhosis as Measured by Child-Pugh Score
por: Raj, Aswin, et al.
Publicado: (2023)

Systemic treatment in patients with Child–Pugh B liver dysfunction and advanced hepatocellular carcinoma
por: Costa, Frederico, et al.
Publicado: (2023)

Clinical impact of carbon‐ion radiotherapy on hepatocellular carcinoma with Child‐Pugh B cirrhosis
por: Hiroshima, Yuichi, et al.
Publicado: (2023)

Cardiomyopathies and Arrhythmias Induced by Cancer Therapies
por: Romitan, Dragoș-Mihai, et al.
Publicado: (2020)

Lipoprotein(a): Role in atherosclerosis and new treatment options
por: Naglic, Dragana Tomic, et al.
Publicado: (2023)

Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma and Child-Pugh A or B cirrhosis
por: FEDERICO, ALESSANDRO, et al.
Publicado: (2015)

Community-Metabolome Correlations of Gut Microbiota from Child-Turcotte-Pugh of A and B Patients
por: Wei, Xiao, et al.
Publicado: (2016)

Response to chemotherapy improves hepatic reserve for patients with hepatocellular carcinoma and Child–Pugh B cirrhosis
por: Terashima, Takeshi, et al.
Publicado: (2016)

Recalibrating the Child–Turcotte–Pugh Score to Improve Prediction of Transplant-Free Survival in Patients with Cirrhosis
por: Kaplan, David E., et al.
Publicado: (2016)

Vitamin D Deficiency and Its Relationship with Child-Pugh Class in Patients with Chronic Liver Disease
por: Jamil, Zubia, et al.
Publicado: (2018)

Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma in Patients With Child-Pugh B or C Cirrhosis
por: Lee, Peter, et al.
Publicado: (2020)

Application of acoustic radiation force impulse elastography combined with serum markers in Child-Pugh grading
por: Wei, Linglin, et al.
Publicado: (2020)

Comparative evaluation of ALBI, MELD, and Child-Pugh scores in prognosis of cirrhosis: is ALBI the new alternative?
por: Fragaki, Maria, et al.
Publicado: (2019)

Generalization of intrinsic ductile-to-brittle criteria by Pugh and Pettifor for materials with a cubic crystal structure
por: Senkov, O. N., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_baolbjk6golc6b8e0vp66re30f